All Companies
Ticker INKT
Below our internal liquidity threshold
You reached the page — here's exactly what INKT is, and why it's out of scope for now.
What this ticker is
INKT
MiNK Therapeutics, Inc.
NASDAQ
Healthcare
Biotechnology
Why we can't analyze it yet
Below internal liquidity floor — trades ~$343,053/day (~$7,204,113/mo), under our $500,000/day minimum; too thin to trade
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
below_liquidity